Global registry probes best treatments for immunotherapy-linked heart trouble
NCT ID NCT07633587
First seen Jun 14, 2026 · Last updated Jun 14, 2026
Summary
This study looks at 1500 cancer patients worldwide who developed heart inflammation (myocarditis) after taking immune checkpoint inhibitors. Researchers want to see if different treatments, like steroids or other immune-suppressing drugs, affect survival at 30, 90, and 360 days. The goal is to find out which treatment approaches work best for different levels of heart inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Pitie-Salpetriere / CIC-2503
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.